Prognostic factors for survival among patients with primary bone sarcomas of small bonesZhan Wang, Zhaoming Ye, Shu Li et al.|Cancer Management and Research|2018Cited by 31
Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling PathwayXiaozhong Liao, Lingling Sun, Wei Guo et al.|Frontiers in Oncology|2020Cited by 19
Yi-Fei-San-Jie Chinese medicine formula reverses immune escape by regulating deoxycholic acid metabolism to inhibit TGR5/STAT3/PD-L1 axis in lung cancerZhiqiang Chen, Jietao Lin, Xiangjun Qi et al.|Phytomedicine|2024Cited by 17
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot StudyWenmin Chen, Lizhu Lin, Zhiwei Xiao et al.|Integrative Cancer Therapies|2023Cited by 6
Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB–IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trialJietao Lin, Lizhu Lin, Xiangjun Qi et al.|Journal of Thoracic Disease|2022Cited by 5